Olympus Co. (OTCMKTS:OLYMY) Short Interest Update

Olympus Co. (OTCMKTS:OLYMY) was the recipient of a large drop in short interest during the month of June. As of June 30th, there was short interest totaling 13 shares, a drop of 99.9% from the June 15th total of 11,090 shares. Based on an average daily volume of 160,531 shares, the short-interest ratio is currently 0.0 days.

Olympus Price Performance

Olympus stock traded up $0.13 on Friday, reaching $10.87. The company’s stock had a trading volume of 31,621 shares, compared to its average volume of 108,660. The business’s fifty day moving average price is $10.82 and its 200 day moving average price is $10.76. Olympus has a twelve month low of $8.08 and a twelve month high of $13.73.

Analyst Ratings Changes

Separately, The Goldman Sachs Group cut shares of Olympus from a “buy” rating to a “neutral” rating in a research note on Monday, June 15th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat, the stock presently has an average rating of “Hold”.

About Olympus

Olympus Corporation is a Tokyo-based manufacturer specializing in precision technology for the medical, scientific and industrial markets. Established in 1919, the company has built an international reputation for optical and digital imaging solutions that encompass endoscopic systems, microscopes, cameras and related accessories. Olympus leverages its expertise in optics, mechanics and electronics to develop instruments designed to advance diagnostics and scientific discovery.

In the healthcare sector, Olympus is best known for its endoscopy products and therapeutic solutions that support minimally invasive procedures in gastroenterology, pulmonology and urology.